British Tobacco Firm To Go Bigger On Vaping

By Internal Contributor

British Tobacco Firm To Go Bigger On Vaping

British tobacco firm Imperial Brands has revealed it is to go "all-in" on vaping after a better than expected full-year revenue and profit.

The maker of Gauloises and Winston cigarettes is now shifting its focus towards the vaping market and is preparing to launch a heated tobacco product in Japan in early 2019, according to a report by Reuters news agency.

Imperial Brands, which reported a net revenue of $39.83 billion for the full-year ending September 30, is also planning to increase investment in its e-cigarette brand blu by around 100 million pounds ($131 million) over the coming six months.

It's plan for "Next Generation Products" (NGP) also includes launching a "connected" e-cigarette in America with built-in age verification, according to the company's CEO Alison Cooper, which it hopes will give peace of mind to those worried about underage vaping.

Cooper told America's CNBC: "We're absolutely focused on the vaping opportunities, it's significant. "We've got a fantastic set of assets in the space including the (vaping) brand blu, we've got proprietary innovation and leading-edge science, all of these things support a really significant opportunity for Imperial so we are going all-in."

News of its investment in heated tobacco will also narrow the gap between Imperial Tobacco and its larger rivals British American and Philip Morris, which already sell "heat not burn" tobacco products worldwide.

Imperial Tobacco reported in its earnings statement how its net revenue rose 2.1 per cent with 0.9 per cent from tobacco and 1.2 per cent from Next Generation Products (NGP) such as e-cigarettes, which was better than analysts average estimate of 7.63 billion.

"In the year ahead, we expect to deliver constant currency revenue growth at, or above, the upper end of our 1-4% revenue growth range driven by consistent growth in tobacco and an acceleration in NGP revenues," the company said in a statement released Tuesday.

Reading next

Marlboro Makers Slammed For Taking Vape Pods Off The Market

Marlboro Makers Slammed For Taking Vape Pods Off The Market

Oct 26, 2018
Internal Contributor
Vaping Set To Wipe Out Tobacco Bonds

Vaping Set To Wipe Out Tobacco Bonds

Nov 23, 2018
Internal Contributor

Leave a comment

This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.

FDA: Disclaimer

The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products and the testimonials made have not been confirmed by FDA- approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your healthcare professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Act requires this notice. SV3 LLC shall not be held liable for the medical claims made by customer testimonials.

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease or ailment. SV3 LLC assumes no responsibility for the improper use of these products. We recommend consulting with a qualified medical doctor or physician when preparing a treatment plan for any and all diseases or ailments. SV3 LLC does not make any health claims about our products and recommend consulting with a qualified medical doctor or physician prior to consuming our products or preparing a treatment plan. It is especially important for those who are pregnant, nursing, chronically ill, elderly or under the age of 18 to discuss the use of these products with a physician prior to consuming. You must be 18 years or older to visit this website and/or purchase SV3 LLC products. The information on our website is intended to provide general information regarding our products and is not to be construed as medical advice or instruction. All products ship in accordance with the PACT Act.

NIXODINE DISCLAIMER

Nixodine is for use by adult (21+) vapor consumers. Underage sale is prohibited. Not Intended for use by minors or pregnant women. Keep out of reach of children and pets. Nixodine is not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease. It is intended only as a satisfying alternative for adult vapor consumers. This is a finished product and should not be mixed with nicotine containing e-liquid. *Warning: Nixodine Could Be Habit Forming*